The U.S. Food and Drug Administration (FDA) has announced an expanded recall of reprocessed electrophysiology and ultrasound catheters manufactured by Medline Industries. The devices may contain residual particulates that pose serious patient safety risks, including infection, embolism, and thrombosis.
The recalled catheters were distributed for clinical use in hospitals and medical facilities across the United States. Healthcare providers using these devices are urged to cease use immediately and review patient records for potential exposure. The specific product lines and lot numbers are detailed in the FDA safety alert.
Medline Industries has initiated the recall in coordination with the FDA. Healthcare facilities should contact their procurement and clinical engineering departments for guidance on device removal and replacement. Patients who received treatment with affected catheters should consult their physicians regarding follow-up care and monitoring. This is a developing story.
Source: Catheter Recall Expansion: Medline Industries Removes Reprocessed Electrophysiology and Ultrasound…
Was this article helpful?
